Telaprevir therapy, renal impairment, and their effects on the pharmacokinetics of tenofovir in HIV/hepatitis C virus coinfected patients

被引：5
|
作者：
Gervasoni, Cristina [1 ]
Milazzo, Laura [1 ]
Pezzani, Diletta [1 ]
Fucile, Serena [2 ]
Cattaneo, Dario [2 ]
机构：
[1] Luigi Sacco Univ Hosp, Div Infect Dis 3, I-20157 Milan, Italy
[2] Luigi Sacco Univ Hosp, Clin Pharmacol Unit, I-20157 Milan, Italy
来源：
AIDS | 2014年 / 28卷 / 02期
关键词：
KIDNEY; ASSOCIATION; EXPOSURE;
D O I：
10.1097/QAD.0000000000000088
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：285 / 287
页数：3
相关论文
共 50 条
  • [21] Time Requirements for Acquisition of Hepatitis C Virus Therapy in HIV/HCV Coinfected Patients
    McLaughlin, Milena
    Kalfayan, Niree
    Grant, Jennifer
    Hawkins, Claudia
    Cottreau, Jessica
    Palella, Frank J., Jr.
    Stosor, Valentina
    JOURNAL OF PHARMACY TECHNOLOGY, 2018, 34 (04) : 149 - 152
  • [22] Interferon therapy in patients coinfected with hepatitis C (HCV) and human immunodeficiency virus (HIV).
    Venkataramani, A
    Rond, R
    Beaumont, C
    Lyche, K
    HEPATOLOGY, 1997, 26 (04) : 738 - 738
  • [23] Cryoglobulinaemia vasculitis in patients coinfected with HIV and hepatitis C virus
    Saadoun, D
    Aaron, L
    Resche-Rigon, M
    Pialoux, G
    Piette, JC
    Cacoub, P
    AIDS, 2006, 20 (06) : 871 - 877
  • [24] Mortality in siblings of patients coinfected with HIV and hepatitis C virus
    Hansen, Ann-Brit Eg
    Gerstoft, Jan
    Kronborg, Gitte
    Pedersen, Court
    Sorensen, Henrik Toft
    Obel, Niels
    JOURNAL OF INFECTIOUS DISEASES, 2007, 195 (02): : 230 - 235
  • [25] Ledipasvir and tenofovir drug interaction in human immunodeficiency virus-hepatitis C virus coinfected patients: Impact on tenofovir trough concentrations and renal safety
    Solas, Caroline
    Bregigeon, Sylvie
    Faucher-Zaegel, Olivia
    Quaranta, Sylvie
    Obry-Roguet, Veronique
    Tamalet, Catherine
    Lacarelle, Bruno
    Poizot-Martin, Isabelle
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (02) : 404 - 409
  • [26] Therapy Insight: management of hepatitis C in patients coinfected with HIV
    Mark S Sulkowski
    Nature Clinical Practice Gastroenterology & Hepatology, 2005, 2 : 223 - 231
  • [27] Therapy Insight: management of hepatitis C in patients coinfected with HIV
    Sulkowski, MS
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2005, 2 (05): : 223 - 231
  • [28] Hepatitis C virus infection is associated with endothelial dysfunction in HIV/hepatitis C virus coinfected patients
    Fernandez de Castro, Isabel
    Micheloud, Dariela
    Berenguer, Juan
    Guzman-Fulgencio, Maria
    Catalan, Pilar
    Miralles, Pilar
    Alvarez, Emilio
    Carlos Lopez, Juan
    Cosin, Jaime
    Lorente, Raquel
    Angeles Munoz-Fernandez, Ma
    Resino, Salvador
    AIDS, 2010, 24 (13) : 2059 - 2067
  • [29] Renal Impairment Is Frequent in Chronic Hepatitis C Patients Under Triple Therapy With Telaprevir or Boceprevir Reply
    Gordon, Stuart C.
    Yee, Leland J.
    Martins, Eduardo Bruno
    HEPATOLOGY, 2014, 59 (06) : 2427 - 2427
  • [30] Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir
    Sheldon, J
    Camino, N
    Rodés, B
    Bartholomeusz, A
    Kuiper, M
    Tacke, F
    Núñez, M
    Mauss, S
    Lutz, T
    Klausen, G
    Lacarnini, S
    Soriano, V
    ANTIVIRAL THERAPY, 2005, 10 (06) : 727 - 734
12345